Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0211 per EA under NDC 64980065501. Its NADAC has been published 44 times since Aug 27, 2025.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980065501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218936On Market Since
2/19/2025
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 44 times since Aug 27, 2025, and over the history we have for it it has declined 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0211 per EA |
|---|---|
| All-time high | $0.0219 (Dec 10, 2025) |
| All-time low | $0.0209 (Mar 18, 2026) |
| 52-week high | $0.0219 |
| 52-week low | $0.0209 |
| Median price | $0.0214 |
| Average price | $0.0214 |
| Largest weekly change | -2.1% (Feb 18, 2026) |
| Weeks tracked | 44 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0211 per EA (NDC 64980065501), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 2.6%. It has been tracked across 44 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Aug 27, 2025, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0209 (Mar 18, 2026) to a high of $0.0219 (Dec 10, 2025), with a median of $0.0214 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE 5 MG TABLET, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 64980065501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification